FDA inspection
JMS Healthcare PHL Inc.: FDA inspection ending May 12, 2023
FDA inspection 1205507 · Voluntary Action Indicated (VAI) · Tanauan City
Key facts
| Inspection ID | 1205507 |
|---|---|
| Firm | JMS Healthcare PHL Inc. |
| FEI number | 3014982186 |
| Address | Lot 2-B-1, Phase 1b, 1st Philippine Ind Park Spec Econ Zone |
| City | Tanauan City |
| Country | Philippines |
| Fiscal year | 2023 |
| Inspection end date | May 12, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data